© 1991 Oxford University Press
research-article |
Development of two types of hepatocellular carcinoma in transgenic mice carrying the SV40 large T-antigen gene
Institute for Medical Genetics, kumamoto University Medical School Kuhonji 4-24-1, Kumamoto 862
1Department of Pathology, Cancer Institute Kami-ikebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan
2To whom requests for reprints should be sent
We produced transgenic mice by introducing a fusion gene (ST) comprising of the promoter for human serum amyloid P component (SAP) and the coding region of the simian virus 40 (SV40) large tumor antigen (Tag). The ST transgenic mice developed hepatocellular carcinomas (HCC) between 7 and 12 weeks of age. Clinically and pathologically these HCC were classified into two types: diffuse and focal. In the diffuse type Tag is expressed in almost all hepatocytes and HCC has presumably developed from these T-antigen-posraVe cells. The focal type, which resembles human HCC, is only Tag positive in the neoplastic nodules. These are surrounded by Tag-negative normal hepatocytes that form normal lobular structures. As the human SAP promoter can direct adult liver-specific expression of heterologous genes, it is assumed that Tag gene expression in the transgenic animals is increased sharply after birth. Interestingly, a similar level of Tag expression was observed in both the cytoplasm and the nucleus. Our results suggest that spatial differences in Tag expression result in the generation of two types of HCC in transgenic mice and that the ST mouse can serve as a model for human hepatocarcinogenesis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Read, G. Hansen, J. Kramer, R. Finch, L. Li, and P. Vogel Ectonucleoside Triphosphate Diphosphohydrolase Type 5 (Entpd5)-Deficient Mice Develop Progressive Hepatopathy, Hepatocellular Tumors, and Spermatogenic Arrest Vet. Pathol., May 1, 2009; 46(3): 491 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nicholes, S. Guillet, E. Tomlinson, K. Hillan, B. Wright, G. D. Frantz, T. A. Pham, L. Dillard-Telm, S. P. Tsai, J.-P. Stephan, et al. A Mouse Model of Hepatocellular Carcinoma : Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice Am. J. Pathol., June 1, 2002; 160(6): 2295 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Enomoto, E. P. Sandgren, and R. R. Maronpot Altered Differentiation of Hepatocytes in a Transgenic Mouse Model of Hepatocarcinogenesis Toxicol Pathol, July 1, 1998; 26(4): 570 - 578. [Abstract] [PDF] |
||||
![]() |
E. Manickan, J. Satoi, T. C. Wang, and T. J. Liang Conditional Liver-specific Expression of Simian Virus 40 T Antigen Leads to Regulatable Development of Hepatic Neoplasm in Transgenic Mice J. Biol. Chem., April 20, 2001; 276(17): 13989 - 13994. [Abstract] [Full Text] [PDF] |
||||



